Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. Guidelines for [[antithrombotic]] therapy for the treatment of [[venous thromboembolism]] (VTE), developed in 2001 by the Sixth [[American College of Chest Physicians]] (ACCP), state that patients with acute VTE should be treated with [[low-molecular-weight heparin]], unfractionated intravenous heparin, or adjusted-dose subcutaneous heparin american_college_of_chest_physicians.txt Last modified: 2024/06/07 02:57by 127.0.0.1